FDA Clears Cepheid’s Multiplex Viral Hemorrhagic Fever Panel
Cepheid, a Danaher operating company, announced on November 3, 2026 that the U.S. Food and Drug Administration had cleared its Xpert Hemorrhagic Fever Panel, a multiplex PCR test designed to deliver results in approximately 61 minutes on GeneXpert Dx systems. The panel provides qualitative detection and identification of viral RNA from a single sample. It covers Ebola virus, including Zaire, Sudan, Taï Forest and Bundibugyo without differentiating among them, as well as Marburg, Lassa and…